Detalhe da pesquisa
1.
Drivers of physician decision-making and patient perspectives across lines of therapy in multiple myeloma in the USA.
Future Oncol
; 19(22): 1549-1562, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37283044
2.
Real-world patient-reported outcomes and concordance between patient and physician reporting of side effects across lines of therapy in multiple myeloma within the USA.
Support Care Cancer
; 31(6): 371, 2023 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268868
3.
Physician treatment preferences for relapsed/refractory multiple myeloma: a discrete choice experiment.
Future Oncol
; 18(25): 2843-2856, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35801416
4.
Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.
Rheumatol Int
; 37(9): 1551-1557, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28455559
5.
"A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
Pharmacoepidemiol Drug Saf
; 25(9): 982-92, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27396534
6.
Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis.
J Manag Care Spec Pharm
; 29(8): 917-926, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523320
7.
Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study.
Leuk Lymphoma
; 64(2): 398-406, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408998
8.
Prescription Market Share and Treatment Patterns in Atopic Dermatitis: A Retrospective Observational Study Using US Insurance Claims.
Adv Ther
; 39(5): 2052-2064, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35287230
9.
The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study.
J Dermatolog Treat
; 33(3): 1707-1717, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33752555
10.
Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy.
J Dermatolog Treat
; 33(5): 2510-2517, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34612129
11.
US health care utilization and costs in adult patients with atopic dermatitis by disease severity.
J Manag Care Spec Pharm
; 28(1): 69-77, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34949118
12.
The direct and indirect costs of adult atopic dermatitis.
J Manag Care Spec Pharm
; 27(10): 1416-1425, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595952
13.
Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials.
Rheumatol Ther
; 8(2): 793-802, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811317
14.
A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods.
Dermatol Ther (Heidelb)
; 11(4): 1305-1318, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34056694
15.
Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis.
Pharmacoecon Open
; 4(1): 105-117, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31177506
16.
A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USA.
Pharmacoeconomics
; 38(1): 39-56, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31452079
17.
Correction to: A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USA.
Pharmacoeconomics
; 38(1): 123, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31712980
18.
Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat-to-Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology.
Arthritis Care Res (Hoboken)
; 72(2): 166-175, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566905
19.
Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.
J Manag Care Spec Pharm
; 25(8): 879-887, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31347977
20.
The Effectiveness of a Private Orthopaedic Practice-Based Osteoporosis Management Service to Reduce the Risk of Subsequent Fractures.
J Bone Joint Surg Am
; 100(21): 1819-1828, 2018 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30399076